CLINICAL PHARMACOKINETICS - A COMPREHENSIVE SYSTEM FOR THERAPEUTIC DRUG-MONITORING AND PRESCRIBING

被引：28

作者：

WHITING, B

KELMAN, AW

BRYSON, SM

DERKX, FHM

THOMSON, AH

FOTHERINGHAM, GH

JOEL, SE

机构：

[1] STOBHILL GEN HOSP,DEPT NUCL MED,GLASGOW G21 3UW,SCOTLAND

[2] W SCOTLAND HLTH BOARDS,DEPT CLIN PHYS & BIOENGN,GLASGOW G4 9LF,SCOTLAND

来源：

BRITISH MEDICAL JOURNAL | 1984年 / 288卷 / 6416期

关键词：

D O I：

10.1136/bmj.288.6416.541

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：541 / 545

页数：5

共 15 条

[1]

BENET LZ, 1980, PHARMACOL BASIS THER, P1675

[2] FACTORS AFFECTING THEOPHYLLINE CLEARANCES - AGE, TOBACCO, MARIHUANA, CIRRHOSIS, CONGESTIVE HEART-FAILURE, OBESITY, ORAL-CONTRACEPTIVES, BENZODIAZEPINES, BARBITURATES, AND ETHANOL [J].

JUSKO, WJ ;

GARDNER, MJ ;

MANGIONE, A ;

SCHENTAG, JJ ;

KOUP, JR ;

VANCE, JW .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (11) :1358-1366

[3] OPT - A PACKAGE OF COMPUTER-PROGRAMS FOR PARAMETER OPTIMIZATION IN CLINICAL PHARMACOKINETICS [J].

KELMAN, AW ;

WHITING, B ;

BRYSON, SM .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) :247-256

[4]

LENERT L, 1982, Clinical Pharmacology and Therapeutics, V31, P243

[5]

LUDDEN TM, 1977, CLIN PHARMACOL THER, V21, P287

[6]

MULLEN PW, 1978, CLIN PHARMACOL THER, V23, P228

[7]

PECK CC, 1980, 4TH P ANN C COMP MED, V2, P988

[8]

RAMBECK B, 1980, THERAPEUTIC DRUG MON, V1, P325

[9]

RICHENS A, 1981, THERAPEUTIC DRUG MON

[10] BAYESIAN INDIVIDUALIZATION OF PHARMACOKINETICS - SIMPLE IMPLEMENTATION AND COMPARISON WITH NON-BAYESIAN METHODS [J].

SHEINER, LB ;

BEAL, SL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (12) :1344-1348

← 1 2 →